Sangiovanni Timothy J. 4
4 · ZEVRA THERAPEUTICS, INC. · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
Zevra (ZVRA) SVP Timothy Sangiovanni Receives Equity Awards
What Happened
Timothy J. Sangiovanni, SVP Finance & Corporate Controller of Zevra Therapeutics (ZVRA), received equity awards on 2026-05-28: a grant of stock options covering 40,000 shares and an award of 20,000 restricted stock units (RSUs). Both awards have a $0 per-share acquisition price reported on the Form 4; these are compensation grants (not open-market purchases or sales).
Key Details
- Transaction date: May 28, 2026; Form 4 filed May 29, 2026 (appears timely).
- Options: 40,000-share option grant (derivative), exercise price reported as $0 on filing; vesting in four equal annual installments beginning March 1, 2027 (subject to continued service).
- RSUs: 20,000 restricted stock units (each converts to one share on settlement); vest one-third on March 1, 2027 and the remaining two-thirds in equal annual installments thereafter (subject to continued service).
- Shares owned after transaction: not specified in the information provided.
- Notable: Grants are governed by the issuer’s 2014 Equity Incentive Plan and are service-vested (no 10b5-1 plan, cashless exercise, or tax-withholding details disclosed in the provided footnotes).
Context
These awards are compensation-related derivative grants: options give the right to buy shares in the future (subject to vesting and plan terms) and RSUs are a contingent right to receive shares when they vest. Such grants are routine for employee compensation and do not by themselves indicate immediate buying or selling activity in the market.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-05-28+40,000→ 40,000 totalExercise: $11.40Exp: 2036-05-27→ Common Stock (40,000 underlying) - Award
Restricted Stock Unit
[F2][F3]2026-05-28+20,000→ 20,000 total→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). The option will vest and become exercisable in four equal annual installments beginning on March 1, 2027, subject to the Reporting Person's continued service on such vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on March 1, 2027, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting Person's continued service through such vesting date.